Mathews Journal of Immunology & Allergy (MJIA; ISSN 2575-9523) is a scholarly journal of international repute that publishes peer-reviewed research on key topics, such as the immune system, innate and adaptive immunity, antibody response, T and B lymphocytes, anaphylaxis, primary immune deficiencies, infectious disease, occupational and environmental allergy, allergic rhinitis, food allergy, angioedema, asthma, atopic dermatitis, antihistamines, and monoclonal antibody generation.
MJIA publishes high-impact clinical and translational research manuscripts aimed at immunologists, allergists, and medical professionals and researchers interested in studying clinical immunology and allergic diseases and associated mechanisms. The journal publishes clinical trials and mechanistic studies investigating novel therapies and providing insights into the underlying mechanisms, with special focus on discoveries that will enrich our understanding of immune and allergy related diseases that will ultimately improve the diagnosis and management of patients affected by these conditions.
MJIA aims to serve as an international forum for showcasing the work of authoritative medical professionals, researchers, and scientists.
Why publish with us?
High Visibility: MJIA follows an open access policy that allows published articles to reach across the globe.
Promotion in Social Media: MJIA promotes articles by providing alerts and regular email updates to subscribers.
Rigorous peer review: Every manuscript submitted undergoes a thorough and rigorous double-blind peer-review. This process eliminates subjective judgments and bias from the decision making process.
We welcome all types of articles related to Immunology & Allergy. Please follow the Author Guidelines. For submission assistance contact: i[email protected].
If you are not sure whether your work is suitable for this journal, please email us at i[email protected] or call us at +1-606-405–6566.
Published : 25th October 2023
Author : Nemat Khansari*
Citation : Khansari N. (2023). Importance of Cancer Vaccines: Progress and Future Developments. Mathews J Immunol Allergy. 7(2):21.
Published : 23rd January 2023
Author : Iyevhobu Kenneth Oshiokhayamhe1,2*
Citation : Iyevhobu KO. (2023). A Review on Penicillinase Production and Beta-Lactamase Activity on Commonly Isolated Bacteria. Mathews J Immunol Allergy. 7(1):20.
Published : 17th January 2023
Authors : Iyevhobu KO*,1,2, Babatope Isaac O3,4, Omolumen LE5, Aliemhe CA6, Igbuan Emmanuel A7
Citation : Iyevhobu KO, et al. (2023). Assessment of Multidrug Resistant Bacteria in Paper Naira Notes. Mathews J Immunol Allergy. 7(1):18.
Published : 17th January 2023
Author : Michel Leclerc*
Citation : Leclerc M. (2023). Complement System in Asterias rubens Genome: Comparisons with Rainbow Trout Complement. Notions of Innate and Adaptative Immunity. Mathews J Immunol Allergy. 7(1):19.
Published : 12th January 2023
Author : Yongxin Zhang*
Citation : Zhang Y. (2023). Role of Autoimmunity in Development of Type 2 Diabetes. Mathews J Immunol Allergy. 7(1):17.
Published : 04th January 2023
Authors : Henry Hongrong Cai, MD* and Ayesha A Pandit, MD MS
Citation : Cai HH and Pandit AA. (2023). FDA Approved Anti-HER2 Therapy for HER+ Cancer. Mathews J Immunol Allergy. 7(1):16.